Cancer Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
Market Overview:
The global cancer diagnostics market size reached US$ 186.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 266.4 Billion by 2028, exhibiting a growth rate (CAGR) of 5.9% during 2023-2028.
Cancer diagnostics represent a range of assessments and procedures executed using sophisticated technologies to identify biomarkers, proteins, tumor type, location, and signs about the stage and presence of various cancerous tumors. They encompass imaging, tumor biopsy, laboratory tests, immunohistochemistry genetic testing, and endoscopic examination as standard assessments. These diagnostics methodologies are performed based on the patient condition and severity of disorders. Apart from this, cancer diagnostics help healthcare practitioners in developing a personalized treatment plan, evaluating specific antigens in a sample tissue by using antibodies, and providing better clinical outcomes through early diagnosis and care. As a result, they are widely adopted in hospitals and laboratories to examine breast, lung, melanoma, and colorectal cancer. Currently, they are mainly available in fluorescent in situ and comparative genomic hybridization technologies.
Cancer Diagnostics Market Trends:
The increasing prevalence of cancer, owing to the rising consumption of alcoholic beverages and tobacco-based products, and the growing need for preventive, diagnostic technologies for better therapeutic effects are majorly driving the market growth. In line with this, significant enhancements in the healthcare sector and the advent of advanced oncological imaging modalities and imaging technologies to detect infections with enhanced accuracy are acting as another growth-inducing factor. Additionally, extensive investments by pharmaceutical companies to engineer cancer vaccines and novel biomarkers for the identification of potential tumor is contributing to the market growth. Moreover, the favorable initiatives being undertaken by non-governmental organizations (NGOs) and healthcare practitioners to sensitize individuals regarding the availability and benefits of early cancer diagnosis, such as instant decision-making and consequent treatment, are propelling the market growth. Other factors, such as the rapid establishment of private diagnostic centers and ongoing research and development (R&D) activities to design effective product variants with reduced treatment, hospitalization, and unavoidable intervention costs, are positively augmenting the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global cancer diagnostics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, technology, application and end user.
Breakup by Product:
Consumables
Antibodies
Kits and Reagents
Probes
Others
Instru
Pathology-based Instruments
Imaging Instruments
Biopsy Instruments
Breakup by Technology:
IVD Testing
Polymerase Chain Reaction (PCR)
In Situ Hybridization (ISH)
Immunohistochemistry (IHC)
Next-generation Sequencing (NGS)
Microarrays
Flow Cytometry
Immunoassays
Others
Imaging
Magnetic Resonance Imaging (MRI)
Computed Tomography (CT)
Positron Emission Tomography (PET)
Mammography
Ultrasound
Biopsy Technique
Breakup by Application:
Breast Cancer
Lung Cancer
Colorectal Cancer
Melanoma
Others
Breakup by End User:
Hospitals and Clinics
Diagnostic Laboratories
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Agilent Technologies Inc., Becton Dickinson and Company, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG (Roche Holding AG), GE HealthCare (General Electric Company), Hologic Inc., Illumina Inc., Koninklijke Philips N.V., Pfizer Inc., Qiagen N.V, Quest Diagnostics, Siemens Healthineers AG (Siemens AG) and Thermo Fisher Scientific Inc.
Key Questions Answered in This Report:
How has the global cancer diagnostics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global cancer diagnostics market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the technology?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global cancer diagnostics market and who are the key players?
What is the degree of competition in the industry?
The global cancer diagnostics market size reached US$ 186.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 266.4 Billion by 2028, exhibiting a growth rate (CAGR) of 5.9% during 2023-2028.
Cancer diagnostics represent a range of assessments and procedures executed using sophisticated technologies to identify biomarkers, proteins, tumor type, location, and signs about the stage and presence of various cancerous tumors. They encompass imaging, tumor biopsy, laboratory tests, immunohistochemistry genetic testing, and endoscopic examination as standard assessments. These diagnostics methodologies are performed based on the patient condition and severity of disorders. Apart from this, cancer diagnostics help healthcare practitioners in developing a personalized treatment plan, evaluating specific antigens in a sample tissue by using antibodies, and providing better clinical outcomes through early diagnosis and care. As a result, they are widely adopted in hospitals and laboratories to examine breast, lung, melanoma, and colorectal cancer. Currently, they are mainly available in fluorescent in situ and comparative genomic hybridization technologies.
Cancer Diagnostics Market Trends:
The increasing prevalence of cancer, owing to the rising consumption of alcoholic beverages and tobacco-based products, and the growing need for preventive, diagnostic technologies for better therapeutic effects are majorly driving the market growth. In line with this, significant enhancements in the healthcare sector and the advent of advanced oncological imaging modalities and imaging technologies to detect infections with enhanced accuracy are acting as another growth-inducing factor. Additionally, extensive investments by pharmaceutical companies to engineer cancer vaccines and novel biomarkers for the identification of potential tumor is contributing to the market growth. Moreover, the favorable initiatives being undertaken by non-governmental organizations (NGOs) and healthcare practitioners to sensitize individuals regarding the availability and benefits of early cancer diagnosis, such as instant decision-making and consequent treatment, are propelling the market growth. Other factors, such as the rapid establishment of private diagnostic centers and ongoing research and development (R&D) activities to design effective product variants with reduced treatment, hospitalization, and unavoidable intervention costs, are positively augmenting the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global cancer diagnostics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, technology, application and end user.
Breakup by Product:
Consumables
Antibodies
Kits and Reagents
Probes
Others
Instru
Pathology-based Instruments
Imaging Instruments
Biopsy Instruments
Breakup by Technology:
IVD Testing
Polymerase Chain Reaction (PCR)
In Situ Hybridization (ISH)
Immunohistochemistry (IHC)
Next-generation Sequencing (NGS)
Microarrays
Flow Cytometry
Immunoassays
Others
Imaging
Magnetic Resonance Imaging (MRI)
Computed Tomography (CT)
Positron Emission Tomography (PET)
Mammography
Ultrasound
Biopsy Technique
Breakup by Application:
Breast Cancer
Lung Cancer
Colorectal Cancer
Melanoma
Others
Breakup by End User:
Hospitals and Clinics
Diagnostic Laboratories
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Agilent Technologies Inc., Becton Dickinson and Company, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG (Roche Holding AG), GE HealthCare (General Electric Company), Hologic Inc., Illumina Inc., Koninklijke Philips N.V., Pfizer Inc., Qiagen N.V, Quest Diagnostics, Siemens Healthineers AG (Siemens AG) and Thermo Fisher Scientific Inc.
Key Questions Answered in This Report:
How has the global cancer diagnostics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global cancer diagnostics market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the technology?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global cancer diagnostics market and who are the key players?
What is the degree of competition in the industry?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL CANCER DIAGNOSTICS MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY PRODUCT
6.1 Consumables
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Antibodies
6.1.2.2 Kits and Reagents
6.1.2.3 Probes
6.1.2.4 Others
6.1.3 Market Forecast
6.2 Instruments
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Pathology-based Instruments
6.2.2.2 Imaging Instruments
6.2.2.3 Biopsy Instruments
6.2.3 Market Forecast
7 MARKET BREAKUP BY TECHNOLOGY
7.1 IVD Testing
7.1.1 Market Trends
7.1.2 Key Segments
7.1.2.1 Polymerase Chain Reaction (PCR)
7.1.2.2 In Situ Hybridization (ISH)
7.1.2.3 Immunohistochemistry (IHC)
7.1.2.4 Next-generation Sequencing (NGS)
7.1.2.5 Microarrays
7.1.2.6 Flow Cytometry
7.1.2.7 Immunoassays
7.1.2.8 Others
7.1.3 Market Forecast
7.2 Imaging
7.2.1 Market Trends
7.2.2 Key Segments
7.2.2.1 Magnetic Resonance Imaging (MRI)
7.2.2.2 Computed Tomography (CT)
7.2.2.3 Positron Emission Tomography (PET)
7.2.2.4 Mammography
7.2.2.5 Ultrasound
7.2.3 Market Forecast
7.3 Biopsy Technique
7.3.1 Market Trends
7.3.2 Market Forecast
8 MARKET BREAKUP BY APPLICATION
8.1 Breast Cancer
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Lung Cancer
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Colorectal Cancer
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Melanoma
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 MARKET BREAKUP BY END USER
9.1 Hospitals and Clinics
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Diagnostic Laboratories
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Others
9.3.1 Market Trends
9.3.2 Market Forecast
10 MARKET BREAKUP BY REGION
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT ANALYSIS
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 VALUE CHAIN ANALYSIS
13 PORTERS FIVE FORCES ANALYSIS
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 PRICE ANALYSIS
15 COMPETITIVE LANDSCAPE
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Abbott Laboratories
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Agilent Technologies Inc.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 Becton Dickinson and Company
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 Bio-Rad Laboratories Inc.
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 F. Hoffmann-La Roche AG (Roche Holding AG)
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 SWOT Analysis
15.3.6 GE HealthCare (General Electric Company)
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7 Hologic Inc.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Illumina Inc.
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Koninklijke Philips N.V.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Pfizer Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Qiagen N.V
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
15.3.12 Quest Diagnostics
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.12.4 SWOT Analysis
15.3.13 Siemens Healthineers AG (Siemens AG)
15.3.13.1 Company Overview
15.3.13.2 Product Portfolio
15.3.13.3 Financials
15.3.13.4 SWOT Analysis
15.3.14 Thermo Fisher Scientific Inc.
15.3.14.1 Company Overview
15.3.14.2 Product Portfolio
15.3.14.3 Financials
15.3.14.4 SWOT Analysis
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL CANCER DIAGNOSTICS MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY PRODUCT
6.1 Consumables
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Antibodies
6.1.2.2 Kits and Reagents
6.1.2.3 Probes
6.1.2.4 Others
6.1.3 Market Forecast
6.2 Instruments
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Pathology-based Instruments
6.2.2.2 Imaging Instruments
6.2.2.3 Biopsy Instruments
6.2.3 Market Forecast
7 MARKET BREAKUP BY TECHNOLOGY
7.1 IVD Testing
7.1.1 Market Trends
7.1.2 Key Segments
7.1.2.1 Polymerase Chain Reaction (PCR)
7.1.2.2 In Situ Hybridization (ISH)
7.1.2.3 Immunohistochemistry (IHC)
7.1.2.4 Next-generation Sequencing (NGS)
7.1.2.5 Microarrays
7.1.2.6 Flow Cytometry
7.1.2.7 Immunoassays
7.1.2.8 Others
7.1.3 Market Forecast
7.2 Imaging
7.2.1 Market Trends
7.2.2 Key Segments
7.2.2.1 Magnetic Resonance Imaging (MRI)
7.2.2.2 Computed Tomography (CT)
7.2.2.3 Positron Emission Tomography (PET)
7.2.2.4 Mammography
7.2.2.5 Ultrasound
7.2.3 Market Forecast
7.3 Biopsy Technique
7.3.1 Market Trends
7.3.2 Market Forecast
8 MARKET BREAKUP BY APPLICATION
8.1 Breast Cancer
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Lung Cancer
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Colorectal Cancer
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Melanoma
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 MARKET BREAKUP BY END USER
9.1 Hospitals and Clinics
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Diagnostic Laboratories
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Others
9.3.1 Market Trends
9.3.2 Market Forecast
10 MARKET BREAKUP BY REGION
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT ANALYSIS
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 VALUE CHAIN ANALYSIS
13 PORTERS FIVE FORCES ANALYSIS
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 PRICE ANALYSIS
15 COMPETITIVE LANDSCAPE
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Abbott Laboratories
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Agilent Technologies Inc.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 Becton Dickinson and Company
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 Bio-Rad Laboratories Inc.
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 F. Hoffmann-La Roche AG (Roche Holding AG)
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 SWOT Analysis
15.3.6 GE HealthCare (General Electric Company)
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7 Hologic Inc.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Illumina Inc.
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Koninklijke Philips N.V.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Pfizer Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Qiagen N.V
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
15.3.12 Quest Diagnostics
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.12.4 SWOT Analysis
15.3.13 Siemens Healthineers AG (Siemens AG)
15.3.13.1 Company Overview
15.3.13.2 Product Portfolio
15.3.13.3 Financials
15.3.13.4 SWOT Analysis
15.3.14 Thermo Fisher Scientific Inc.
15.3.14.1 Company Overview
15.3.14.2 Product Portfolio
15.3.14.3 Financials
15.3.14.4 SWOT Analysis
LIST OF TABLES
Table 1: Global: Cancer Diagnostics Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Cancer Diagnostics Market Forecast: Breakup by Product (in Million US$), 2023-2028
Table 3: Global: Cancer Diagnostics Market Forecast: Breakup by Technology (in Million US$), 2023-2028
Table 4: Global: Cancer Diagnostics Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 5: Global: Cancer Diagnostics Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 6: Global: Cancer Diagnostics Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 7: Global: Cancer Diagnostics Market: Competitive Structure
Table 8: Global: Cancer Diagnostics Market: Key Players
Table 1: Global: Cancer Diagnostics Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Cancer Diagnostics Market Forecast: Breakup by Product (in Million US$), 2023-2028
Table 3: Global: Cancer Diagnostics Market Forecast: Breakup by Technology (in Million US$), 2023-2028
Table 4: Global: Cancer Diagnostics Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 5: Global: Cancer Diagnostics Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 6: Global: Cancer Diagnostics Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 7: Global: Cancer Diagnostics Market: Competitive Structure
Table 8: Global: Cancer Diagnostics Market: Key Players
LIST OF FIGURES
Figure 1: Global: Cancer Diagnostics Market: Major Drivers and Challenges
Figure 2: Global: Cancer Diagnostics Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Cancer Diagnostics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Cancer Diagnostics Market: Breakup by Product (in %), 2022
Figure 5: Global: Cancer Diagnostics Market: Breakup by Technology (in %), 2022
Figure 6: Global: Cancer Diagnostics Market: Breakup by Application (in %), 2022
Figure 7: Global: Cancer Diagnostics Market: Breakup by End User (in %), 2022
Figure 8: Global: Cancer Diagnostics Market: Breakup by Region (in %), 2022
Figure 9: Global: Cancer Diagnostics (Consumables) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Cancer Diagnostics (Consumables) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Cancer Diagnostics (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Cancer Diagnostics (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Cancer Diagnostics (IVD Testing) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Cancer Diagnostics (IVD Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Cancer Diagnostics (Imaging) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Cancer Diagnostics (Imaging) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Cancer Diagnostics (Biopsy Technique) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Cancer Diagnostics (Biopsy Technique) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Cancer Diagnostics (Breast Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Cancer Diagnostics (Breast Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Cancer Diagnostics (Lung Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Cancer Diagnostics (Lung Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Cancer Diagnostics (Colorectal Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Cancer Diagnostics (Colorectal Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Cancer Diagnostics (Melanoma) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Cancer Diagnostics (Melanoma) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Cancer Diagnostics (Other Cancers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Cancer Diagnostics (Other Cancers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Cancer Diagnostics (Hospitals and Clinics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Cancer Diagnostics (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: Cancer Diagnostics (Diagnostic Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: Cancer Diagnostics (Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Global: Cancer Diagnostics (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Global: Cancer Diagnostics (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: North America: Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: North America: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: United States: Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: United States: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Canada: Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: Canada: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Asia-Pacific: Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Asia-Pacific: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: China: Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: China: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: Japan: Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: Japan: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: India: Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: India: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: South Korea: Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: South Korea: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: Australia: Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: Australia: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: Indonesia: Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: Indonesia: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: Others: Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: Others: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: Europe: Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: Europe: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Germany: Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Germany: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: France: Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: France: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: United Kingdom: Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: United Kingdom: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Italy: Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Italy: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Spain: Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Spain: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Russia: Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Russia: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Others: Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Others: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Latin America: Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Latin America: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Brazil: Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Brazil: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Mexico: Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Mexico: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Others: Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 80: Others: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: Middle East and Africa: Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 82: Middle East and Africa: Cancer Diagnostics Market: Breakup by Country (in %), 2022
Figure 83: Middle East and Africa: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 84: Global: Cancer Diagnostics Industry: SWOT Analysis
Figure 85: Global: Cancer Diagnostics Industry: Value Chain Analysis
Figure 86: Global: Cancer Diagnostics Industry: Porter's Five Forces Analysis
Figure 1: Global: Cancer Diagnostics Market: Major Drivers and Challenges
Figure 2: Global: Cancer Diagnostics Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Cancer Diagnostics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Cancer Diagnostics Market: Breakup by Product (in %), 2022
Figure 5: Global: Cancer Diagnostics Market: Breakup by Technology (in %), 2022
Figure 6: Global: Cancer Diagnostics Market: Breakup by Application (in %), 2022
Figure 7: Global: Cancer Diagnostics Market: Breakup by End User (in %), 2022
Figure 8: Global: Cancer Diagnostics Market: Breakup by Region (in %), 2022
Figure 9: Global: Cancer Diagnostics (Consumables) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Cancer Diagnostics (Consumables) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Cancer Diagnostics (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Cancer Diagnostics (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Cancer Diagnostics (IVD Testing) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Cancer Diagnostics (IVD Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Cancer Diagnostics (Imaging) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Cancer Diagnostics (Imaging) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Cancer Diagnostics (Biopsy Technique) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Cancer Diagnostics (Biopsy Technique) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Cancer Diagnostics (Breast Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Cancer Diagnostics (Breast Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Cancer Diagnostics (Lung Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Cancer Diagnostics (Lung Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Cancer Diagnostics (Colorectal Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Cancer Diagnostics (Colorectal Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Cancer Diagnostics (Melanoma) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Cancer Diagnostics (Melanoma) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Cancer Diagnostics (Other Cancers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Cancer Diagnostics (Other Cancers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Cancer Diagnostics (Hospitals and Clinics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Cancer Diagnostics (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: Cancer Diagnostics (Diagnostic Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: Cancer Diagnostics (Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Global: Cancer Diagnostics (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Global: Cancer Diagnostics (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: North America: Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: North America: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: United States: Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: United States: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Canada: Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: Canada: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Asia-Pacific: Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Asia-Pacific: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: China: Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: China: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: Japan: Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: Japan: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: India: Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: India: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: South Korea: Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: South Korea: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: Australia: Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: Australia: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: Indonesia: Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: Indonesia: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: Others: Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: Others: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: Europe: Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: Europe: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Germany: Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Germany: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: France: Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: France: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: United Kingdom: Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: United Kingdom: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Italy: Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Italy: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Spain: Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Spain: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Russia: Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Russia: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Others: Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Others: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Latin America: Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Latin America: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Brazil: Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Brazil: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Mexico: Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Mexico: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Others: Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 80: Others: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: Middle East and Africa: Cancer Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 82: Middle East and Africa: Cancer Diagnostics Market: Breakup by Country (in %), 2022
Figure 83: Middle East and Africa: Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 84: Global: Cancer Diagnostics Industry: SWOT Analysis
Figure 85: Global: Cancer Diagnostics Industry: Value Chain Analysis
Figure 86: Global: Cancer Diagnostics Industry: Porter's Five Forces Analysis
